Cullinan oncology to participate in the evercore isi 4th annual healthconx conference

Cambridge, mass., nov. 22, 2021 (globe newswire) -- cullinan oncology, inc. (nasdaq: cgem), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology therapies, today announced that it will be participating in the 4th annual evercore isi healthconx conference from november 30th to december 2nd, 2021.
CGEM Ratings Summary
CGEM Quant Ranking